KenarJhaveri United StatesNorthwell Health

KenarJhaveri
Kenar Jhaveri, MD is a Professor of Medicine at the Zucker School of Medicine at Hofstra/Northwell and Associate Chief of Nephrology at Northwell health, NY. He is a leader in glomerular diseases and onconephrology. He is currently the editor in chief of ASN Kidney News.
Upload Picture
https://storage.unitedwebnetwork.com/files/1099/39820a8d22df4375d3473ce267a804eb.jpg
First name
Kenar
Last name
Jhaveri
Institution
Country
United States

Friday, February 7, 2025

Time Session
9:45 a.m.
11:15 a.m.
Kidney-Cancer Intersections: Complications, Checkpoints and Abnormalities - Charting a Course
IK01
GeorgiAbraham Chair IndiaMGM Healthcare, Chennai, India
KriangTungsanga Chair ThailandDepartment of Medicine, Faculty of Medicine, Chulalongkorn Unviersity
SanjayD'Cruz Chair IndiaGovernment Medical College & Hospital, Chandigarh
  • Renal Complications of Novel Cancer Therapies: Practical Insights
    IK01-01
    AnushreeShirali Speaker United StatesYale University
  • Immune Checkpoint Inhibitors and AKI
    IK01-02
    MitchellRosner Speaker United StatesUniveristy of Virginia Health
  • Electrolyte Abnormalities in the Cancer Patient
    IK01-03
    JolantaMalyszko Speaker PolandMedical University of Warsaw, Poland
  • Opening an Onconephrology Clinic - What Should You Be Aware of?
    IK01-04
    KenarJhaveri Speaker United StatesNorthwell Health
  • Q&A
    IK01-05
Amaltas Hall B101-A

Thursday, February 6, 2025

Time Session
9 a.m.
11 a.m.
Annual Review of Nephrology Course: Managing Kidney Failure
NAR1
KenarJhaveri Chair United StatesNorthwell Health
MitchellRosner Chair United StatesUniveristy of Virginia Health
  • New Solutions to Anemia Management in Kidney Failure: The Role of HIF-PH Inhibitors
    NAR1-01
    JolantaMalyszko Speaker PolandMedical University of Warsaw, Poland
  • New Solutions to Phosphorus Control in Kidney Failure: Achieving Patient Goals
    NAR1-02
    KrishnaswamySampathkumar Speaker IndiaMeenakshi Mission Hospital
  • Improving Volume and Hypertension Control in Kidney Failure: New Approaches to a Critical Issue?
    NAR1-03
    Angela Yee-MoonWang Speaker SingaporeHong Kong/Singapore
  • Q and A
    NAR1-04
Neelkamal Hall 305
11:30 a.m.
1:30 p.m.
Annual Review of Nephrology Course: Best Practices in Diabetic Kidney Disease Care
NAR2
KenarJhaveri Chair United StatesNorthwell Health
MitchellRosner Chair United StatesUniveristy of Virginia Health
  • Clinical Trials Overview: Focus on GLP1a, MRA, and SGLT2
    NAR2-01
    MaartenTaal Speaker United KingdomUniversity of Nottingham
  • SGLT2i Versus GLP1a And/or MRA Versus SGLT2i, And/or Starting All Together: What Should the Clinician Do? My Approach
    NAR2-02
    KatherineTuttle Speaker United StatesUniversity of Washington School of Medicine, Division of Nephrology
  • SGLT2i Versus GLP1a And/or MRA Versus SGLT2i, And/or Starting All Together: What Should the Clinician Do? My Approach
    NAR2-03
    MadhukarMisra Speaker United StatesUniversity of Missouri Columbia, USA
  • Q and A
    NAR2-04
Neelkamal Hall 305
2:15 p.m.
4:15 p.m.
Annual Review of Nephrology Course: Electrolyte Management in the ICU
NAR3
KenarJhaveri Chair United StatesNorthwell Health
MitchellRosner Chair United StatesUniveristy of Virginia Health
  • Approaches to the Patient with Severe Hyponatremia and Acute Kidney Injury
    NAR3-01
    MitchellRosner Speaker United StatesUniveristy of Virginia Health
  • Approaches to Severe Hypercalcemia
    NAR3-02
    KenarJhaveri Speaker United StatesNorthwell Health
  • Approaches to Severe Hyperkalemia
    NAR3-03
    KSNayak Speaker IndiaVirinchi Hospitals
  • Q and A
    NAR3-04
Neelkamal Hall 305